{"id":"csa-low-dose","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nephrotoxicity"},{"rate":"10-20%","effect":"Hypertension"},{"rate":"5-10%","effect":"Diabetes mellitus"}]},"_chembl":{"chemblId":"CHEMBL2108580","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This inhibition prevents the transcription of interleukin-2 (IL-2), a cytokine that promotes T-cell proliferation. As a result, CsA suppresses the immune response, which is beneficial in preventing organ rejection in transplant patients.","oneSentence":"CsA works by inhibiting calcineurin, a protein phosphatase involved in the activation of T-lymphocytes.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:43.029Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of organ rejection in kidney transplant patients"}]},"trialDetails":[{"nctId":"NCT06816134","phase":"PHASE2","title":"Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2025-01-30","conditions":"Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Transplantation, Stem Cell","enrollment":48},{"nctId":"NCT04195633","phase":"PHASE2","title":"Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies","status":"RECRUITING","sponsor":"Fred Hutchinson Cancer Center","startDate":"2021-01-25","conditions":"Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia","enrollment":60},{"nctId":"NCT05600426","phase":"PHASE3","title":"A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Boston Children's Hospital","startDate":"2023-01-25","conditions":"Severe Aplastic Anemia","enrollment":53},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT06500143","phase":"","title":"Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2024-10-09","conditions":"Gastric Retention","enrollment":94},{"nctId":"NCT07297550","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of the JAK1 Inhibitor Combined With Intensive Immunosuppressive Therapy in Severe Aplastic Anemia","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-12-15","conditions":"Severe Aplastic Anemia, Refractory Aplastic Anemia, Newly Diagnosed Aplastic Anemia","enrollment":42},{"nctId":"NCT07239128","phase":"EARLY_PHASE1","title":"Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus","status":"COMPLETED","sponsor":"University of Seville","startDate":"2024-05-01","conditions":"Dry Eye Disease (DED)","enrollment":160},{"nctId":"NCT07164833","phase":"PHASE2","title":"A Study to Evaluate the Efficacy and Safety of BX-001N in Preventing Cardiac Surgery-Associated Acute Kidney Injury (CSA-AKI) and Major Adverse Kidney Events (MAKE)","status":"RECRUITING","sponsor":"Bilix Co.,Ltd.","startDate":"2025-08-26","conditions":"Ischemia Reperfusion Injury, Cardiac Surgery Associated - Acute Kidney Injury","enrollment":40},{"nctId":"NCT01282073","phase":"PHASE3","title":"Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"Kyungpook National University Hospital","startDate":"2011-03","conditions":"Glomerulonephritis, Membranous","enrollment":43},{"nctId":"NCT07021495","phase":"","title":"SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)","status":"RECRUITING","sponsor":"Leiden University Medical Center","startDate":"2025-07-29","conditions":"Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), Psoriasis (PsO)","enrollment":840},{"nctId":"NCT03456817","phase":"PHASE2","title":"HIgh Dose Thymoglobulin Instead of Cyclosporine With a Low Dose of Thymoglobulin for GVHD Prophylaxis","status":"TERMINATED","sponsor":"AHS Cancer Control Alberta","startDate":"2020-07-01","conditions":"Graft-versus-host-disease, Relapse","enrollment":68},{"nctId":"NCT06246786","phase":"EARLY_PHASE1","title":"Breast/Cyclosporin A/TNBC (Triple Negative Breast Cancer)","status":"WITHDRAWN","sponsor":"Virginia G. Kaklamani","startDate":"2024-07-01","conditions":"Triple Negative Breast Cancer, DNA Damage Repair Deficiency","enrollment":""},{"nctId":"NCT05153070","phase":"PHASE2","title":"Ciclosporin Followed by Low-dose IL-2 in Patients With Recently Diagnosed Type 1 Diabetes","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-09-21","conditions":"Type 1 Diabetes","enrollment":24},{"nctId":"NCT05855954","phase":"NA","title":"Application of CLCVP Technique in Early Intervention of CSA-AKI","status":"RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2023-05-01","conditions":"Acute Kidney Injury","enrollment":200},{"nctId":"NCT06995274","phase":"NA","title":"Umbilical Cord Blood Therapy in a Child With Eosinophilic Duodenitis and Autism Spectrum Disorder: a Case Study","status":"NOT_YET_RECRUITING","sponsor":"Bundang CHA Hospital","startDate":"2025-06-01","conditions":"Autism Spectrum Disorder, Eosinophilic Gastrointestinal Disorders","enrollment":1},{"nctId":"NCT02845596","phase":"NA","title":"Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia","status":"COMPLETED","sponsor":"Michael Pulsipher","startDate":"2016-08","conditions":"Severe Aplastic Anemia","enrollment":40},{"nctId":"NCT01701258","phase":"PHASE1","title":"An Investigation of Early Life Stress and Depression","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2013-08","conditions":"Major Depressive Disorder (MDD), History of Childhood Sexual Abuse (CSA)","enrollment":153},{"nctId":"NCT02618577","phase":"PHASE3","title":"Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes","status":"TERMINATED","sponsor":"Atrial Fibrillation Network","startDate":"2016-02","conditions":"Atrial High Rate Episodes","enrollment":2608},{"nctId":"NCT03710044","phase":"PHASE4","title":"Investigation of Flare and Remission in Subjects With Atopic Dermatitis","status":"WITHDRAWN","sponsor":"LEO Pharma","startDate":"2019-01-14","conditions":"Atopic Dermatitis","enrollment":""},{"nctId":"NCT06676696","phase":"PHASE4","title":"Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure","status":"RECRUITING","sponsor":"Hospital Universitari Vall d'Hebron Research Institute","startDate":"2024-01-22","conditions":"Renal Failure , Chronic, Graft Failure, Graft Rejection","enrollment":202},{"nctId":"NCT01002339","phase":"PHASE4","title":"Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation","status":"TERMINATED","sponsor":"Armando Torres Ramírez","startDate":"2010-02","conditions":"Diabetes Mellitus, Adult-Onset","enrollment":134},{"nctId":"NCT04681833","phase":"PHASE2","title":"Safety and Efficacy of BARS13 in the Elderly","status":"COMPLETED","sponsor":"Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.","startDate":"2021-05-24","conditions":"Respiratory Syncytial Virus Infections","enrollment":125},{"nctId":"NCT03840291","phase":"PHASE4","title":"Resolution of Thrombi in Left Atrial Appendage With Edoxaban","status":"COMPLETED","sponsor":"Keimyung University Dongsan Medical Center","startDate":"2019-05-19","conditions":"Atrial Fibrillation, Left Atrial Appendage Thrombosis","enrollment":36},{"nctId":"NCT06490562","phase":"NA","title":"Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-07","conditions":"Acute Graft-versus-host Disease","enrollment":66},{"nctId":"NCT06447090","phase":"PHASE2","title":"VMAC+DLI Treatment of Patients With Relapse of AML After Allo-HSCT","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2024-04-12","conditions":"Relapse Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT01041508","phase":"PHASE1","title":"Clofarabine and Low Dose Total Body Irradiation as a Preparative Regimen for Stem Cell Transplant in Leukemia.","status":"COMPLETED","sponsor":"Therapeutic Advances in Childhood Leukemia Consortium","startDate":"2010-01-29","conditions":"Leukemia Lymphoblastic, Acute, Acute Myeloid Leukemia, Neoplasm Recurrent","enrollment":18},{"nctId":"NCT00752479","phase":"PHASE1, PHASE2","title":"Mesenchymal Stem Cells Under Basiliximab/Low Dose RATG to Induce Renal Transplant Tolerance","status":"TERMINATED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2008-05","conditions":"Kidney Transplant","enrollment":4},{"nctId":"NCT00571662","phase":"PHASE2","title":"Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2000-12-08","conditions":"Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia","enrollment":76},{"nctId":"NCT03608059","phase":"PHASE4","title":"ATG/PTCy in Haplo-PBSCT Randomized Controlled,Multi-center","status":"COMPLETED","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2018-07-28","conditions":"Myeloid Tumor","enrollment":418},{"nctId":"NCT04107675","phase":"PHASE2","title":"A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4)","status":"TERMINATED","sponsor":"Zambon SpA","startDate":"2020-02-11","conditions":"Bronchiolitis Obliterans Syndrome (BOS), GVHD, Chronic, Stem Cell Transplant Complications","enrollment":6},{"nctId":"NCT00816413","phase":"PHASE1, PHASE2","title":"Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer","status":"WITHDRAWN","sponsor":"University of Nebraska","startDate":"2008-09","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":""},{"nctId":"NCT04072068","phase":"PHASE4","title":"Study on Impact of Edoxaban Treatment in Cancer Patients With Venous Thromboembolism During Antineoplastic Therapy","status":"COMPLETED","sponsor":"Gruppo Oncologico Italiano di Ricerca Clinica","startDate":"2019-06-27","conditions":"Thromboembolism, Cancer","enrollment":150},{"nctId":"NCT05782933","phase":"NA","title":"Efficacy of Rituximab Combined With Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2022-08-04","conditions":"Idiopathic Membranous Nephropathy","enrollment":2},{"nctId":"NCT04688021","phase":"PHASE2","title":"A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.","status":"UNKNOWN","sponsor":"Yi Luo","startDate":"2020-12-03","conditions":"Leukemia, Graft-versus-host-disease","enrollment":46},{"nctId":"NCT05634915","phase":"PHASE4","title":"Clinical Study of rATG Individualized Administration in Haploidentical Hematopoietic Stem Cell Transplantation","status":"UNKNOWN","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2022-12-20","conditions":"Hematopoietic Stem Cell Transplantation, Acute Leukemia","enrollment":90},{"nctId":"NCT00119366","phase":"PHASE2","title":"Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2003-05","conditions":"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)","enrollment":18},{"nctId":"NCT01976390","phase":"NA","title":"Comparing Everolimus and Sirolimus in Renal Transplant Recipients","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2013-10-01","conditions":"Renal Failure","enrollment":60},{"nctId":"NCT00579709","phase":"PHASE1","title":"Thymus Transplantation With Immunosuppression","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2002-07","conditions":"DiGeorge Syndrome, DiGeorge Anomaly, Complete DiGeorge Anomaly","enrollment":15},{"nctId":"NCT00849888","phase":"PHASE1","title":"Serum-Free Thymus Transplantation in DiGeorge Anomaly","status":"TERMINATED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2008-04","conditions":"DiGeorge Anomaly","enrollment":2},{"nctId":"NCT04907058","phase":"NA","title":"Central Sleep Apnea Treated by CO2 Supplied by a Novel Device","status":"COMPLETED","sponsor":"State Key Laboratory of Respiratory Disease","startDate":"2021-05-20","conditions":"Central Sleep Apnea","enrollment":18},{"nctId":"NCT00579527","phase":"PHASE1, PHASE2","title":"Phase I/II Thymus Transplantation With Immunosuppression #950","status":"COMPLETED","sponsor":"Sumitomo Pharma Switzerland GmbH","startDate":"2005-12-19","conditions":"DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly","enrollment":14},{"nctId":"NCT00919503","phase":"PHASE2","title":"Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2009-07-31","conditions":"Non-Neoplastic Hematologic and Lymphocytic Disorder","enrollment":98},{"nctId":"NCT01434472","phase":"PHASE2","title":"High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Lymphoma","status":"TERMINATED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2011-11-16","conditions":"Post-Transplant Lymphoproliferative Disorder, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma","enrollment":20},{"nctId":"NCT04906304","phase":"NA","title":"Comparison of Safety and Efficacy of de Novo Everolimus","status":"COMPLETED","sponsor":"Shahid Beheshti University of Medical Sciences","startDate":"2020-01-01","conditions":"Cytomegalovirus Infections","enrollment":35},{"nctId":"NCT04851977","phase":"PHASE1","title":"A First in Human Study to Evaluate the Safety and Immune Response to a Vaccine for the Treatment of a Respiratory Virus, When Administered Into the Arm in Healthy Adult Participants","status":"COMPLETED","sponsor":"Advaccine (Suzhou) Biopharmaceuticals Co., Ltd.","startDate":"2018-10-16","conditions":"Respiratory Syncytial Virus Infections","enrollment":60},{"nctId":"NCT01062555","phase":"PHASE1, PHASE2","title":"Calcineurin Inhibitor Sparing After Kidney Transplantation","status":"COMPLETED","sponsor":"University of Minnesota","startDate":"2006-10-01","conditions":"CNI Side Effects","enrollment":527},{"nctId":"NCT04202887","phase":"NA","title":"The Effect of Low-Dose vs High-Dose Epidural Fentanyl on Gastric Emptying - A Prospective Double-Blinded Randomized Controlled Trial","status":"UNKNOWN","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2020-07-30","conditions":"Effects of; Anesthesia, Spinal and Epidural, in Pregnancy, Aspiration","enrollment":81},{"nctId":"NCT04540926","phase":"PHASE1, PHASE2","title":"Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia","status":"UNKNOWN","sponsor":"Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado","startDate":"2020-09","conditions":"COVID 19 Pneumonia","enrollment":200},{"nctId":"NCT00303719","phase":"PHASE2","title":"Allogeneic Bone Marrow Transplantation Using Less Intensive Therapy","status":"TERMINATED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2002-03-26","conditions":"Kidney Cancer, Leukemia, Lymphoma","enrollment":342},{"nctId":"NCT01252667","phase":"PHASE2","title":"Clofarabine and Low-Dose Total-Body Irradiation in Treating Patients With Acute Myeloid Leukemia Undergoing Donor Peripheral Blood Stem Cell Transplant","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2011-01-25","conditions":"Acute Myeloid Leukemia","enrollment":44},{"nctId":"NCT02199964","phase":"NA","title":"The Effects of Cyclosporin A in a Low Humidity Environment, on the Ocular Surface","status":"TERMINATED","sponsor":"Baylor College of Medicine","startDate":"2014-03","conditions":"Dry Eye","enrollment":4},{"nctId":"NCT00553098","phase":"PHASE2","title":"Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by a Donor Stem Cell Transplant in Treating Patients With Immunodeficiency or Other Nonmalignant Inherited Disorders","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2006-06","conditions":"Immunodeficiency Syndrome, Non-Cancer Diagnosis","enrollment":29},{"nctId":"NCT00003954","phase":"PHASE1, PHASE2","title":"Melphalan and Stem Cell Transplant Before Total-Body Irradiation and Donor Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1999-03","conditions":"Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma","enrollment":40},{"nctId":"NCT00096161","phase":"PHASE2","title":"Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2003-05","conditions":"Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia","enrollment":36},{"nctId":"NCT00397813","phase":"PHASE2","title":"Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2006-01","conditions":"Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome","enrollment":77},{"nctId":"NCT00040846","phase":"PHASE2","title":"Alemtuzumab, Fludarabine Phosphate, and Low-Dose Total Body Irradiation Before Donor Stem Cell Transplantation in Treating Patients With Hematological Malignancies","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2001-11","conditions":"Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)","enrollment":60},{"nctId":"NCT04237987","phase":"PHASE2","title":"Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy","status":"UNKNOWN","sponsor":"Peking University People's Hospital","startDate":"2020-01-21","conditions":"Inflammatory Myopathy","enrollment":20},{"nctId":"NCT00014235","phase":"NA","title":"Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2000-12","conditions":"Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission","enrollment":160},{"nctId":"NCT00006251","phase":"PHASE1, PHASE2","title":"Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2000-05","conditions":"Acute Undifferentiated Leukemia, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma","enrollment":21},{"nctId":"NCT00003145","phase":"PHASE2","title":"Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Older Patients With Chronic Myeloid Leukemia","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1997-08","conditions":"Accelerated Phase of Disease, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive","enrollment":18},{"nctId":"NCT00003196","phase":"NA","title":"Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1997-09","conditions":"Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma","enrollment":63},{"nctId":"NCT00027820","phase":"PHASE1, PHASE2","title":"Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2001-08","conditions":"Adult Acute Myeloid Leukemia in Remission, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission","enrollment":106},{"nctId":"NCT04203108","phase":"PHASE4","title":"ATG in HLA-matched Sibling HSCT as GVHD Prophylaxis","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2019-09-01","conditions":"Hematopoietic Stem Cell Transplantation","enrollment":266},{"nctId":"NCT00085449","phase":"PHASE1, PHASE2","title":"Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer","status":"WITHDRAWN","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2006-05","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":""},{"nctId":"NCT00008177","phase":"PHASE1","title":"Radiolabeled Monoclonal Antibody Therapy, Fludarabine Phosphate, and Low-Dose Total-Body Irradiation Followed by Donor Stem Cell Transplant and Immunosuppression Therapy in Treating Older Patients With Advanced Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1999-07-27","conditions":"Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q)","enrollment":79},{"nctId":"NCT02864706","phase":"PHASE4","title":"SCHEDULE Follow Up Visit 5-7 yr","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2016-01-18","conditions":"Heart Transplantation","enrollment":95},{"nctId":"NCT00044954","phase":"PHASE2","title":"Total-Body Irradiation, Fludarabine, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"University of Texas Southwestern Medical Center","startDate":"1999-11","conditions":"Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm","enrollment":""},{"nctId":"NCT01581970","phase":"PHASE2","title":"Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-06","conditions":"Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma","enrollment":7},{"nctId":"NCT00005799","phase":"NA","title":"Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"1999-11","conditions":"Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission","enrollment":55},{"nctId":"NCT00005851","phase":"PHASE1, PHASE2","title":"Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Stage IV Kidney Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2000-02","conditions":"Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer","enrollment":11},{"nctId":"NCT00104858","phase":"PHASE2","title":"Fludarabine Phosphate, Radiation Therapy, and Rituximab in Treating Patients Who Are Undergoing Donor Stem Cell Transplant Followed by Rituximab for High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2004-12","conditions":"Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Recurrent Small Lymphocytic Lymphoma","enrollment":66},{"nctId":"NCT01878786","phase":"PHASE2, PHASE3","title":"A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys","status":"TERMINATED","sponsor":"Matthew Cooper","startDate":"2013-06","conditions":"Delayed Graft Function","enrollment":25},{"nctId":"NCT03170323","phase":"PHASE4","title":"Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy","status":"UNKNOWN","sponsor":"Guangdong Provincial People's Hospital","startDate":"2018-07-01","conditions":"Idiopathic Membranous Nephropathy","enrollment":128},{"nctId":"NCT00928018","phase":"PHASE3","title":"Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma","status":"COMPLETED","sponsor":"Dana-Farber Cancer Institute","startDate":"2009-06","conditions":"Non-hodgkin Lymphoma, Hodgkin Lymphoma","enrollment":139},{"nctId":"NCT00074490","phase":"PHASE2","title":"Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2004-01-01","conditions":"Lymphoma, Leukemia, Myeloproliferative Disorders","enrollment":442},{"nctId":"NCT00331162","phase":"PHASE4","title":"Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2005-02","conditions":"Graft Rejection","enrollment":222},{"nctId":"NCT00154284","phase":"PHASE3","title":"Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant Patients","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-07","conditions":"Organ Transplantation, Renal Transplantation","enrollment":114},{"nctId":"NCT00119392","phase":"PHASE2","title":"Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, Radiation Therapy, and Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2004-06","conditions":"B-cell Chronic Lymphocytic Leukemia, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma","enrollment":42},{"nctId":"NCT02701517","phase":"PHASE2","title":"Cyclosporine Plus Methotrexate or Alemtuzumab","status":"TERMINATED","sponsor":"Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea","startDate":"2003-09","conditions":"Unrecognized Condition: Mature B or T-cell Neoplasm","enrollment":72},{"nctId":"NCT01626092","phase":"NA","title":"Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders","status":"COMPLETED","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2012-07-11","conditions":"Lysosomal Storage Disease, Peroxisomal Disorder","enrollment":3},{"nctId":"NCT00425802","phase":"PHASE2","title":"Chemotherapy, Total-Body Irradiation, Rituximab, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2006-11-28","conditions":"Leukemia, Lymphoma","enrollment":61},{"nctId":"NCT00054353","phase":"PHASE1, PHASE2","title":"Reduced-Intensity Conditioning Followed By Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Multiple Myeloma","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2002-10","conditions":"Refractory Multiple Myeloma","enrollment":16},{"nctId":"NCT00281879","phase":"PHASE2","title":"Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer","status":"TERMINATED","sponsor":"OHSU Knight Cancer Institute","startDate":"2006-02","conditions":"Chronic Myeloproliferative Disorders, Leukemia, Lymphoma","enrollment":200},{"nctId":"NCT01410448","phase":"PHASE3","title":"Everolimus in de Novo Kidney Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-11","conditions":"Kidney Transplantation","enrollment":383},{"nctId":"NCT01313923","phase":"EARLY_PHASE1","title":"Evaluating Sirolimus to Treat Autoimmune Blistering Dermatosis Pemphigus","status":"TERMINATED","sponsor":"University of California, Irvine","startDate":"2011-02","conditions":"Pemphigus","enrollment":3},{"nctId":"NCT00118352","phase":"PHASE2","title":"Alemtuzumab, Fludarabine Phosphate, and Total-Body Irradiation Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2005-03","conditions":"Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission","enrollment":12},{"nctId":"NCT01193283","phase":"PHASE1, PHASE2","title":"Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia","status":"COMPLETED","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2010-08","conditions":"Aplastic Anemia, Neutropenia, Pancytopenia","enrollment":22},{"nctId":"NCT00075478","phase":"PHASE3","title":"Total-Body Irradiation With or Without Fludarabine Phosphate Followed By Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2003-10","conditions":"Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Aggressive Non-Hodgkin Lymphoma","enrollment":87},{"nctId":"NCT01830920","phase":"PHASE2","title":"A Study of THR-184 in Patients at Risk of Developing Cardiac Surgery Associated-Acute Kidney Injury (CSA-AKI)","status":"COMPLETED","sponsor":"Thrasos Innovation, Inc.","startDate":"2013-05","conditions":"Acute Kidney Injury","enrollment":452},{"nctId":"NCT00093743","phase":"PHASE1","title":"Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia","status":"COMPLETED","sponsor":"Fred Hutchinson Cancer Center","startDate":"2000-01","conditions":"Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q)","enrollment":2},{"nctId":"NCT01954784","phase":"PHASE1","title":"Lenalidomide After Donor Stem Cell Transplant and Bortezomib in Treating Patients With High Risk Multiple Myeloma","status":"TERMINATED","sponsor":"Case Comprehensive Cancer Center","startDate":"2013-10-07","conditions":"Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma","enrollment":8},{"nctId":"NCT00514514","phase":"PHASE3","title":"Study Investigating a Standard Regimen in de Novo Kidney Transplant Patients Versus a Calcineurin Inhibitor (CNI)-Free Regimen and a CNI-low Dose Regimen","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-07","conditions":"Kidney Transplantation","enrollment":802},{"nctId":"NCT00504543","phase":"PHASE2","title":"Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-07","conditions":"Kidney Transplantation","enrollment":311},{"nctId":"NCT01222039","phase":"PHASE1, PHASE2","title":"Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.","status":"COMPLETED","sponsor":"Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud","startDate":"2010-06","conditions":"Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease, Immune System Diseases","enrollment":19},{"nctId":"NCT01514968","phase":"PHASE1","title":"A Drug-Drug Interaction Study Between Danoprevir/Low-Dose Ritonavir and Cyclosporine in Healthy Volunteers","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2011-12","conditions":"Healthy Volunteer","enrollment":18},{"nctId":"NCT00048152","phase":"PHASE3","title":"A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2000-12","conditions":"Kidney Transplantation","enrollment":539},{"nctId":"NCT01654211","phase":"PHASE1","title":"A Pharmacokinetic And Bioavailability Study of Intravenous Danoprevir in Healthy Volunteers","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2012-07","conditions":"Healthy Volunteer","enrollment":33},{"nctId":"NCT00023244","phase":"PHASE2","title":"Steroid Withdrawal in Pediatric Kidney Transplant Recipients","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-01","conditions":"End-Stage Renal Disease","enrollment":274},{"nctId":"NCT01023815","phase":"PHASE3","title":"Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.","status":"COMPLETED","sponsor":"Novartis","startDate":"2009-04","conditions":"de Novo Kidney Transplant Recipients, Renal Transplantation","enrollment":330},{"nctId":"NCT00775632","phase":"PHASE2","title":"Alemtuzumab and Cyclosporine for the Prevention of Graft vs Host Disease After Stem Cell Transplants","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2008-10","conditions":"Graft Versus Host Disease, Bone Marrow Transplantation","enrollment":78}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":13,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"CsA low dose","genericName":"CsA low dose","companyName":"Fovea Pharmaceuticals SA","companyId":"fovea-pharmaceuticals-sa","modality":"Small molecule","firstApprovalDate":"","aiSummary":"CsA works by inhibiting calcineurin, a protein phosphatase involved in the activation of T-lymphocytes. Used for Prevention of organ rejection in kidney transplant patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}